Cite

HARVARD Citation

    Perrone, S. et al. (2022). Management of relapsed or refractory large B-cell lymphoma in patients ineligible for CAR-T cell therapy. Expert review of hematology. 15 (3), pp. 215-232. [Online]. 
  
Back to record